Average Co-Inventor Count = 10.40
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (16 from 3,923 patents)
2. Astex Therapeutics Limited (1 from 123 patents)
16 patents:
1. 12209098 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
2. 11952386 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
3. 11401259 - 1-Pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2
4. 10968235 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
5. 10774065 - 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2
6. 10336774 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
7. 10093646 - 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2
8. 10077276 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
9. RE46942 - 4-piperidinyl compounds for use as tankyrase inhibitors
10. 9163003 - 4-piperidinyl compounds for use as tankyrase inhibitors
11. 8598217 - Imidazole derivatives and their use as modulators of cyclin dependent kinases
12. 8552003 - (S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-4-(4-fluorobenzoyl)-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide, or pharmaceutically acceptable salts thereof and their uses
13. 8546336 - SMAC peptidometics useful as IAP inhibitors
14. 8349883 - Hydroxamate-based inhibitors of deacetylases B
15. 8044209 - Pyrrolydine derivatives as IAP inhibitors